{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T01:58:44Z","timestamp":1749088724293,"version":"3.37.3"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,3,22]],"date-time":"2023-03-22T00:00:00Z","timestamp":1679443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,3,22]],"date-time":"2023-03-22T00:00:00Z","timestamp":1679443200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100006087","name":"National Center on Birth Defects and Developmental Disabilities","doi-asserted-by":"publisher","award":["5U01DD00116"],"award-info":[{"award-number":["5U01DD00116"]}],"id":[{"id":"10.13039\/100006087","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Direct estimates of rare disease prevalence from public health surveillance may only be available in a few catchment areas. Understanding variation among observed prevalence can inform estimates of prevalence in other locations. The Muscular Dystrophy Surveillance, Tracking, and Research Network (MD STAR<jats:italic>net<\/jats:italic>) conducts population-based surveillance of major muscular dystrophies in selected areas of the United States. We identified sources of variation in prevalence estimates of Duchenne and Becker muscular dystrophy (DBMD) within MD STAR<jats:italic>net<\/jats:italic> from published literature and a survey of MD STAR<jats:italic>net<\/jats:italic> investigators, then developed a logic model of the relationships between the sources of variation and estimated prevalence.\n<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The 17 identified sources of variability fell into four categories: (1) inherent in surveillance systems, (2) particular to rare diseases, (3) particular to medical-records-based surveillance, and (4) resulting from extrapolation. For the sources of uncertainty measured by MD STAR<jats:italic>net,<\/jats:italic> we estimated each source\u2019s contribution to the total variance in DBMD prevalence. Based on the logic model we fit a multivariable Poisson regression model to 96 age\u2013site\u2013race\/ethnicity strata. Age accounted for 74% of the variation between strata, surveillance site for 6%, race\/ethnicity for 3%, and 17% remained unexplained.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Variation in estimates derived from a non-random sample of states or counties may not be explained by demographic differences alone. Applying these estimates to other populations requires caution.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13023-023-02662-0","type":"journal-article","created":{"date-parts":[[2023,3,22]],"date-time":"2023-03-22T10:02:56Z","timestamp":1679479376000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Sources of variation in estimates of Duchenne and Becker muscular dystrophy prevalence in the United States"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2908-3503","authenticated-orcid":false,"given":"Nedra","family":"Whitehead","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen W.","family":"Erickson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzanne","family":"McDermott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Holly","family":"Peay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James F.","family":"Howard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lijing","family":"Ouyang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"the Muscular Dystrophy Surveillance, Tracking and Research Network","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,3,22]]},"reference":[{"key":"2662_CR1","unstructured":"Porta M, ed. A Dictionary of Epidemiology. 6th ed. New York: Oxford University Press. ISBN: 978-0-19-997673-7."},{"issue":"3","key":"2662_CR2","first-page":"3","volume":"61","author":"SB Thacker","year":"2012","unstructured":"Thacker SB, Qualters JR, Lee LM, et al. Public health surveillance in the United States: evolution and challenges. MMWR Suppl. 2012;61(3):3\u20139.","journal-title":"MMWR Suppl"},{"key":"2662_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/medicina57020119","author":"D Taruscio","year":"2021","unstructured":"Taruscio D, Mantovani A. Multifactorial rare diseases: can uncertainty analysis bring added value to the search for risk factors and etiopathogenesis. Medicina. 2021. https:\/\/doi.org\/10.3390\/medicina57020119.","journal-title":"Medicina"},{"issue":"19","key":"2662_CR4","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1002\/bdr2.1371","volume":"110","author":"TN Do","year":"2018","unstructured":"Do TN, Street N, Donnelly J, et al. Muscular dystrophy surveillance, tracking, and research network pilot: population-based surveillance of major muscular dystrophies at four US sites, 2007\u20132011. Birth Defects Res. 2018;110(19):1404\u201311. https:\/\/doi.org\/10.1002\/bdr2.1371.","journal-title":"Birth Defects Res"},{"issue":"11","key":"2662_CR5","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1002\/bdra.20279","volume":"76","author":"LA Miller","year":"2006","unstructured":"Miller LA, Romitti PA, Cunniff C, et al. The muscular dystrophy surveillance tracking and research network (MD STARnet): surveillance methodology. Birth Defects Res A Clin Mol Teratol. 2006;76(11):793\u20137. https:\/\/doi.org\/10.1002\/bdra.20279.","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"key":"2662_CR6","unstructured":"Centers for Disease C, Prevention. Prevalence of Duchenne\/Becker muscular dystrophy among males aged 5\u201324 years - four states, 2007. MMWR Morb Mortal Wkly Rep 2009;58(40):1119\u201322."},{"issue":"3","key":"2662_CR7","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1542\/peds.2014-2044","volume":"135","author":"PA Romitti","year":"2015","unstructured":"Romitti PA, Zhu Y, Puzhankara S, et al. Prevalence of Duchenne and Becker muscular dystrophies in the United States. Pediatrics. 2015;135(3):513\u201321. https:\/\/doi.org\/10.1542\/peds.2014-2044.","journal-title":"Pediatrics"},{"issue":"1","key":"2662_CR8","doi-asserted-by":"publisher","first-page":"143","DOI":"10.2307\/2982708","volume":"154","author":"J Besag","year":"1991","unstructured":"Besag J, Newell J. The detection of clusters in rare disease. J R Stat Soc A Stat Soc. 1991;154(1):143\u201355. https:\/\/doi.org\/10.2307\/2982708.","journal-title":"J R Stat Soc A Stat Soc"},{"key":"2662_CR9","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1750-1172-6-16","volume":"6","author":"CE Hollak","year":"2011","unstructured":"Hollak CE, Aerts JM, Ayme S, et al. Limitations of drug registries to evaluate orphan medicinal products for the treatment of lysosomal storage disorders. Orphanet J Rare Dis. 2011;6:16. https:\/\/doi.org\/10.1186\/1750-1172-6-16.","journal-title":"Orphanet J Rare Dis"},{"issue":"3","key":"2662_CR10","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1002\/art.11122","volume":"49","author":"EP Mendez","year":"2003","unstructured":"Mendez EP, Lipton R, Ramsey-Goldman R, et al. US incidence of juvenile dermatomyositis, 1995\u20131998: results from the national institute of arthritis and musculoskeletal and skin diseases registry. Arthritis Rheum. 2003;49(3):300\u20135. https:\/\/doi.org\/10.1002\/art.11122.","journal-title":"Arthritis Rheum"},{"issue":"3","key":"2662_CR11","first-page":"288","volume":"23","author":"JB Yu","year":"2009","unstructured":"Yu JB, Gross CP, Wilson LD, et al. NCI SEER public-use data: applications and limitations in oncology research. Oncology. 2009;23(3):288\u201395.","journal-title":"Oncology"},{"issue":"3","key":"2662_CR12","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1093\/ije\/25.3.474","volume":"25","author":"L Papoz","year":"1996","unstructured":"Papoz L, Balkau B, Lellouch J. Case counting in epidemiology: limitations of methods based on multiple data sources. Int J Epidemiol. 1996;25(3):474\u20138. https:\/\/doi.org\/10.1093\/ije\/25.3.474.","journal-title":"Int J Epidemiol"},{"issue":"9","key":"2662_CR13","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1177\/0883073810371001","volume":"25","author":"KD Mathews","year":"2010","unstructured":"Mathews KD, Cunniff C, Kantamneni JR, et al. Muscular dystrophy surveillance tracking and research network (MD STARnet): case definition in surveillance for childhood-onset Duchenne\/Becker muscular dystrophy. J Child Neurol. 2010;25(9):1098\u2013102. https:\/\/doi.org\/10.1177\/0883073810371001.","journal-title":"J Child Neurol"},{"key":"2662_CR14","unstructured":"SurveyGizmo [program]. https:\/\/www.alchemer.com\/survey\/. Alchemer. Louisville, CO."},{"key":"2662_CR15","unstructured":"Rothman KJ. Standardization of rates. Modern Epidemiology. Boston, MA: Little, Brown and Company 1986:42\u201344."},{"key":"2662_CR16","unstructured":"Bates D et al. R: A language and environment for statistical computing. [program]. 3.4.3 version. Vienna, Austria: R Foundation for Statistical Computing, 2017. https:\/\/www.R-project.org."},{"key":"2662_CR17","unstructured":"Bates D et al. R: A language and environment for statistical computing. [program]. 3.6.0 version. Vienna, Austria: R Foundation for Statistical Computing, 2019. https:\/\/www.R-project.org."},{"key":"2662_CR18","unstructured":"Base SAS\u00ae 9.4 Procedures Guide, Seventh Edition.\nCary, NC: SAS Institute Inc. https:\/\/www.sas.com."}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-023-02662-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-023-02662-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-023-02662-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,22]],"date-time":"2023-03-22T10:05:00Z","timestamp":1679479500000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-023-02662-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,22]]},"references-count":18,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2662"],"URL":"https:\/\/doi.org\/10.1186\/s13023-023-02662-0","relation":{},"ISSN":["1750-1172"],"issn-type":[{"type":"electronic","value":"1750-1172"}],"subject":[],"published":{"date-parts":[[2023,3,22]]},"assertion":[{"value":"27 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study complies with the guidelines for human studies and was conducted ethically in accordance with the World Medical Association Declaration of Helsinki. As described in the manuscript, all four sites had authority to conduct public health surveillance by the legal authority of their state department of health and\/or institutional review board approval or exemption.(3) Informed consent was waived because the project was public health surveillance.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"No individual data included.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no competing interests to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"65"}}